What can we help you find?

Leading the way in transplantation

Filter results for:

The COVID-19 Vaccine Studies

February 16, 2021 | Allograft | Basic science | Cell | Composite tissue | Education | Ethics, Law and Psychosocial | Heart | Intestine | Islets | Kidney | Liver | Lung | Non-organ specific | Organ donation | Organ regeneration | Pancreas | Patients | Self-management | TLJ | Transplant coordination | Transplant nursing | Xenograft

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe.

Furthermore, our patients and the broader transplant community deserve be kept informed about published peer reviewed literature related to COVID-19 vaccinations, especially for immunosuppressed and immunocompromised patients and the opportunity to appraise and discuss it.

We sincerely hope that this new ESOT initiative will be helpful for our healthcare professionals and patients.

Vassilios Papalois – ESOT President

Learn more about the new Library